MannKind Corporation
Heat-stable dry powder pharmaceutical compositions and methods
Last updated:
Abstract:
Disclosed herein are heat-stable dry powders which include peptides or protein such as oxytocin for use as a pharmaceutical composition. The composition is highly stable at increased temperatures and relatively high humid environments, and are intended for storage at room temperature with an improved shelf-life. In particular, the dry powders are intended for inhalation, however, other routes of administration can be used when reconstituted in solution.
Status:
Grant
Type:
Utility
Filling date:
1 Aug 2019
Issue date:
25 May 2021